Trade Repligen Corp - RGEN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.80 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 144.69 |
| Open | 142.28 |
| 1-Year Change | -14.56% |
| Day's Range | 142.28 - 144.85 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 25, 2025 | 144.69 | 1.74 | 1.22% | 142.95 | 145.27 | 141.36 |
| Apr 24, 2025 | 144.85 | 3.47 | 2.45% | 141.38 | 145.43 | 139.16 |
| Apr 23, 2025 | 141.23 | -2.23 | -1.55% | 143.46 | 148.72 | 140.64 |
| Apr 22, 2025 | 138.76 | 0.81 | 0.59% | 137.95 | 141.12 | 136.01 |
| Apr 21, 2025 | 131.48 | 5.52 | 4.38% | 125.96 | 132.12 | 125.96 |
| Apr 17, 2025 | 129.93 | 1.37 | 1.07% | 128.56 | 131.26 | 125.11 |
| Apr 16, 2025 | 132.04 | 5.09 | 4.01% | 126.95 | 134.47 | 126.95 |
| Apr 15, 2025 | 126.41 | 4.46 | 3.66% | 121.95 | 129.86 | 121.95 |
| Apr 14, 2025 | 126.98 | 6.89 | 5.74% | 120.09 | 128.76 | 120.09 |
| Apr 11, 2025 | 122.80 | 9.01 | 7.92% | 113.79 | 123.03 | 110.39 |
| Apr 10, 2025 | 115.13 | 2.31 | 2.05% | 112.82 | 118.61 | 110.33 |
| Apr 9, 2025 | 123.77 | 18.75 | 17.85% | 105.02 | 124.17 | 105.01 |
| Apr 8, 2025 | 108.84 | -9.91 | -8.35% | 118.75 | 118.75 | 105.71 |
| Apr 7, 2025 | 116.00 | 11.05 | 10.53% | 104.95 | 120.33 | 103.95 |
| Apr 4, 2025 | 111.73 | -4.77 | -4.09% | 116.50 | 116.91 | 106.73 |
| Apr 3, 2025 | 121.65 | 0.96 | 0.80% | 120.69 | 125.28 | 120.20 |
| Apr 2, 2025 | 130.86 | 6.07 | 4.86% | 124.79 | 132.72 | 124.79 |
| Apr 1, 2025 | 128.42 | 0.84 | 0.66% | 127.58 | 128.65 | 124.57 |
| Mar 31, 2025 | 127.18 | -2.77 | -2.13% | 129.95 | 130.48 | 125.34 |
| Mar 28, 2025 | 133.29 | -2.21 | -1.63% | 135.50 | 136.92 | 130.30 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Repligen Company profile
About Repligen Corporation
Repligen Corporation is a life sciences company that develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, Filtration; Chromatography; Process Analytics; and Proteins. The Filtration products are used in process development and process scale (clinical and commercial) production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Repligen Corporation revenues increased 83% to $670.5M. Net income increased from $59.9M to $128.3M. Revenues reflect Product revenue - Filtration products segment increase from $174.9M to $403.5M, Product revenue - Protein products segment increase of 53% to $123.7M, Europe segment increase of 83% to $254.8M, North America segment increase of 56% to $274.9M.
Equity composition
Common Stock $.01 Par, 01/11, 40M auth., 30,787,307 issd. Insiders & strategic holders own 13.21%. PO 5/91, 2M shares @ $12.50 by Lehman Bros. Public Offering 2/94, 2.9M shares @ $6 by Lehman Brothers.
| Industry: | Medical Equipment, Supplies & Distribution (NEC) |
Building 1, Suite 100
41 Seyon Street
WALTHAM
MASSACHUSETTS 02453
US
News
GME shares price forecast: Third-party price target
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
11:40, 28 April 2025
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com